Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
5 Patents
#5 in Brighton
#3,217 in United Kingdom
Destiny Pharma Limited
Forward Citations = 17
9 inventors:
Destiny Pharma Limited
Calculating rank
% Expired Patents = 20.0
CIPO Patents = 2
EPO Patents = 2
Forward Citations = 17
Loading Chart...
Loading Chart...
9 inventors (with patents filed for the assignee):
William Guy Love (5 out of 11 patents)
William Rhys-Williams (5 out of 5 patents)
Derek Brundish (3 out of 3 patents)
4. Benoit Pugin (2 out of 20 patents)
5. Xiang Feng (1 out of 2 patents)
6. Andrew W Lloyd (1 out of 2 patents)
7. Matteo Santin (1 out of 5 patents)
8. Xiang Dong Feng (1 out of 1 patent)
9. Stephen P Denyer (1 out of 1 patent)
10. William Love (0 patent)
11. William G Love (0 patent)
12. William G Love (0 patent)
5 patents:
Company Overview
Destiny Pharma is a clinical-stage biotechnology company focused on the development of novel anti-infectives to prevent infections. Their lead product XF-73 is being developed for the prevention of post-surgical infections, resistant bacterial infections and hospital-acquired infections. They are also working on other pipeline products that target drug-resistant infections.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Destiny Pharma Limited. Retrieved from https://idiyas.com/company/destiny-pharma
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]